Publications by authors named "Pranita Kaphle"

The transplantation of collagen hydrogels encapsulating human dental pulp stem cell (DPSC)-derived chondrogenic cells is potentially a novel approach for the regeneration of degenerated nucleus pulposus (NP) and cartilage. Grafted cell migration allows cells to disperse in the hydrogels and the treated tissue from the grafted location. We previously reported the cell migration in type I and type II hydrogels.

View Article and Find Full Text PDF
Article Synopsis
  • Structural variants (SVs), particularly enhancer hijacking, can change chromatin structures and activate oncogenes in human cancers, but the mechanisms behind these effects are not well understood.
  • A new multimodal approach combining genome analysis and other techniques helped identify both known and novel pathogenic SVs, including a specific translocation linked to pediatric leukemia that activates the TLX3 gene.
  • The study found that the interaction between genetic changes (like SVs) and chromatin states affects gene expression, suggesting that understanding these interactions might lead to new treatment strategies for leukemia.
View Article and Find Full Text PDF

The branched-chain aminotransferase isozymes BCAT1 and BCAT2, segregated into distinct subcellular compartments and tissues, initiate the catabolism of branched-chain amino acids (BCAAs). However, whether and how BCAT isozymes cooperate with downstream enzymes to control BCAA homeostasis in an intact organism remains largely unknown. Here, we analyse system-wide metabolomic changes in BCAT1- and BCAT2-deficient mouse models.

View Article and Find Full Text PDF
Article Synopsis
  • Mutations in IDH genes are common in acute myeloid leukemia (AML) and lead to the production of a harmful substance, R-2HG; treatments targeting mutant IDH have shown effectiveness but face challenges due to emerging drug resistance.
  • Researchers used CRISPR technology to create leukemia cells with specific IDH mutations and discovered new mutations that cause resistance by blocking the effectiveness of enzyme inhibitors.
  • The study highlights a new set of mutations that enable cancer cells to overcome therapies aimed at inhibiting IDH, providing insight into how cancer can evade targeted treatments.
View Article and Find Full Text PDF

Cancers develop from the accumulation of somatic mutations, yet it remains unclear how oncogenic lesions cooperate to drive cancer progression. Using a mouse model harboring NRas and EZH2 mutations that recapitulates leukemic progression, we employ single-cell transcriptomic profiling to map cellular composition and gene expression alterations in healthy or diseased bone marrows during leukemogenesis. At cellular level, NRas induces myeloid lineage-biased differentiation and EZH2-deficiency impairs myeloid cell maturation, whereas they cooperate to promote myeloid neoplasms with dysregulated transcriptional programs.

View Article and Find Full Text PDF

Tissue-specific gene expression requires coordinated control of gene-proximal and -distal cis-regulatory elements (CREs), yet functional analysis of gene-distal CREs such as enhancers remains challenging. Here we describe CRISPR/dCas9-based enhancer-targeting epigenetic editing systems, enCRISPRa and enCRISPRi, for efficient analysis of enhancer function in situ and in vivo. Using dual effectors capable of re-writing enhancer-associated chromatin modifications, we show that enCRISPRa and enCRISPRi modulate gene transcription by remodeling local epigenetic landscapes at sgRNA-targeted enhancers and associated genes.

View Article and Find Full Text PDF

The invasion of glioblastoma is a complex process based on the interactions of tumor cells and the extracellular matrix. Tumors that are engineered using biomaterials are more physiologically relevant than a two-dimensional (2D) cell culture system. Matrix metalloproteinases and the plasminogen activator generated by tumor cells regulate a tumor's invasive behavior.

View Article and Find Full Text PDF